Institute of Chemistry and Biochemistry , Freie Universität Berlin , Takustraße 3 , 14195 Berlin , Germany.
J Am Chem Soc. 2019 Jan 23;141(3):1222-1226. doi: 10.1021/jacs.8b13356. Epub 2019 Jan 9.
A synthetic approach to recently reported and structurally unique 11(9→7) abeo-steroids pleurocin A/matsutakone (1) and pleurocin B (2) was developed by reconsidering the originally suggested polar transformations of their biogenesis. An intricate radical cyclization of a late stage intermediate followed by an oxidative quench was used instead and forged the abeo-framework, while the 9,11-seco-motif was obtained by conversion of ergosterol into a 9,11-secoenol ether employing a mercury-free desaturation of the Treibs type, an oxidative bond scission preluding a dioxa-[4+2]-cycloaddition of an aldehyde to an enone and a combined transacetalization/elimination followed by an ionic hydrogenation.
开发了一种新的合成方法,用于合成最近报道的结构独特的 11(9→7)abeo-甾体pleurocin A/matsutakone (1) 和 pleurocin B (2),通过重新考虑它们生物合成中原先提出的极性转化。采用复杂的晚期中间体的自由基环化,然后进行氧化淬灭,从而构建了 abeo 骨架,而 9,11-桥环基序则通过将麦角甾醇转化为 9,11-桥烯醇醚来获得,该转化采用无汞 Treibs 型去饱和、氧化键断裂、醛到烯酮的二氧杂-[4+2]-环加成、缩醛化/消除的组合,然后进行离子氢化。